Detalles de la búsqueda
1.
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study.
Front Immunol
; 14: 1194671, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37449202
2.
Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies.
Front Immunol
; 13: 926318, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35990701
Resultados
1 -
2
de 2
1
Próxima >
>>